Clinical profile and mortality predictors for tuberculosis disease among patients with solid tumours

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
INFECTIOUS DISEASES, v.54, n.11, p.804-809, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The characteristics of Mycobacterium tuberculosis (MTb) disease are still obscure in patients with solid tumours, as well as the benefits of screening and treating latent tuberculosis infection (LTBI) in these patients. Our objective was to trace the clinical profile of these individuals and assess the mortality predictors related to tuberculosis (TB). Methods We reviewed the medical records of 126 patients with solid tumours malignancy and who developed TB disease between January 2009 and April 2018 at a cancer referral centre. Results The most common locations of malignancy were head and neck, with squamous cell carcinoma being the most frequent histological type, the majority (97/126) presenting locally invasive tumours (T3 or T4). A total of 120 had TB pulmonary and the microbiological diagnosis was performed in 103/126. The following variables were associated with the risk of death from TB: DPOC lung cancer, BMI, malnutrition, metastasis and ECOG 3 or 4. Previous chemotherapy treatment was a protective factor. Conclusions Male, usage of alcohol and smoking were the most predominant patients characteristics in our sample. In the multivariate analysis, lung cancer, presence of metastasis and ECOG >= 3 were associated with death from TB.
Palavras-chave
Tuberculosis, chemotherapy, cancer, solid tumours, malignancy, Mycobacterium tuberculosis
Referências
  1. Cakar B, 2018, RESPIR MED CASE REP, V23, P33, DOI 10.1016/j.rmcr.2017.11.004
  2. Cheng MP, 2017, CLIN INFECT DIS, V64, P635, DOI 10.1093/cid/ciw838
  3. Huang SF, 2011, GASTRIC CANCER, V14, P257, DOI 10.1007/s10120-011-0037-1
  4. Jung WJ, 2016, WORLD J GASTROENTERO, V22, P2585, DOI 10.3748/wjg.v22.i8.2585
  5. Kamboj M, 2006, CLIN INFECT DIS, V42, P1592, DOI 10.1086/503917
  6. Kim DK, 2005, CHEST, V128, P2218, DOI 10.1378/chest.128.4.2218
  7. Kim HR, 2008, RESPIROLOGY, V13, P413, DOI 10.1111/j.1440-1843.2008.01282.x
  8. Lai SW, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000008366, 10.1097/md.0000000000008366]
  9. Lang S, 2017, EXP THER MED, V14, P2180, DOI 10.3892/etm.2017.4737
  10. Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308
  11. Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939
  12. World Health Organization 2021, GLOBAL TUBERCULOSIS